|
FOR
IMMEDIATE RELEASE
February 10, 2022
Contact:
CMS Media Relations
CMS Media Inquiries
CMS Expands Coverage of
Lung Cancer Screening with Low Dose Computed Tomography
Final decision improves health outcomes for people with
lung cancer
Today
the Centers for Medicare & Medicaid Services (CMS) is announcing a
national coverage determination (NCD) that expands coverage for lung
cancer screening with low dose computed tomography (LDCT) to improve
health outcomes for people with lung cancer. Lung cancer is one of the
most common cancers and the leading cause of cancer-related death in
both men and women in the United States. This screening is aimed at
early detection of non-small cell lung cancer.
This
final decision expands eligibility for people with Medicare to get lung
cancer screening with LCDT by lowering the starting age for screening
from 55 to 50 years and reducing the tobacco smoking history from at
least 30 packs per year to at least 20 packs per year. The only
recommended screening test for lung cancer is LDCT, a unique computed
tomography (CT) scan technique that combines special x-ray equipment
with sophisticated computers to produce multiple, cross-sectional
images of the inside of the body.
“Expanding
coverage broadens access for lung cancer screening to at-risk
populations,” said CMS Chief Medical Officer and Director of the Center
for Clinical Standards and Quality, Dr. Lee Fleisher. “Today’s decision
not only expands access to quality care but is also critical to
improving health outcomes for people by helping to detect lung cancer
earlier.”
The
final decision also simplifies requirements for the counseling and
shared decision-making visit and, based on public comments received on
the proposed NCD and additional review, removes the requirement for the
reading radiologist to document participation in continuing medical
education, thereby reducing administrative burden on providers. CMS
also added a requirement back to the NCD criteria for radiology imaging
facilities to use a standardized lung nodule identification,
classification, and reporting system.
To
read the final decision, visit the CMS website at: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=304
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on
Twitter @CMSgov
|
No comments:
Post a Comment